Excessive GRK2 activity is, therefore, considered a key contributor to endothelial dysfunction and insulin resistance (Ciccarelli et al., 2011), positioning GRK2 as a molecular bridge between metabolic dysregulation and vascular pathology. The gene discussed is GRK2; the disease is Insulin resistance.